BioAdaptives, Inc.
BDPT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | 66.3% | -13.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 31.8% | 37.9% | 41.5% | 51.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $0 | $1 |
| Operating Income | -$1 | -$0 | -$0 | -$1 |
| % Margin | -4,751.8% | -801.7% | -2,456.9% | -3,216% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -7,096.1% | -2,492.6% | -5,216.6% | -5,309.5% |
| EPS | -0.11 | -0.12 | -1.27 | -4.67 |
| % Growth | 8.3% | 90.6% | 72.8% | – |
| EPS Diluted | -0.11 | -0.12 | -1.27 | -4.67 |
| Weighted Avg Shares Out | 8 | 6 | 1 | 0 |
| Weighted Avg Shares Out Dil | 8 | 6 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -4,595.1% | -1,823.9% | -3,167.2% | -3,256.5% |